Pat PurcellMeeting Engagement
David LinetskyPoint-of-Care Marketing
Stacey GandlerBrand Nourishment
Daniel SontupeMarket Access
Bud BilanichSuccess Coach
Matt TurnerPatient Affordability
Suma Ramadas, PhDMedical Affairs
Paul TheisenPatient Acquisition
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
Amy GilesIncreasing Engagement
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
Liz KaneImpactful Strategy
Completed merger with PharmAthene, began trading on NASDAQ as Altimmune, Inc. (ALT) Remains on ...
No Significant CA4P Drug Safety Issues IdentifiedInitial Efficacy in Favor of CA4P, with 22% ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email